• 南京醫(yī)科大學(xué)第一附屬醫(yī)院 江蘇省人民醫(yī)院 胸心外科, 南京 210096;

目的 比較一種改良三尖瓣成形術(shù)與Kay 成形術(shù)的成形效果,總結(jié)治療經(jīng)驗。 方法 回顧性分析江蘇省人民醫(yī)院2006 年1 月至2008 年1 月60 例功能性三尖瓣反流患者的臨床資料。按手術(shù)方式不同將60 例患者分為兩組:改良三尖瓣成形術(shù)組(改良組),30 例,其中男14 例,女16 例;年齡(42.80±5.70)歲;Kay 成形術(shù)組,30 例,其中男15 例,女15 例;年齡(45.30±8.30)歲。術(shù)前兩組患者的年齡、性別、心功能分級(NYHA)和三尖瓣反流分級差異均無統(tǒng)計學(xué)意義(P > 0.05)。比較兩組患者術(shù)前、術(shù)后住院及術(shù)后隨訪期間的右心房橫徑、右心室舒張期末內(nèi)徑和三尖瓣反流面積。 結(jié)果 兩組患者手術(shù)時間、體外循環(huán)時間、住重癥監(jiān)護室時間、呼吸機輔助時間、住院時間差異均無統(tǒng)計學(xué)意義。術(shù)后全部患者痊愈出院。改良組隨訪時間為(19.62±8.65)個月,遠(yuǎn)期1 例死于肺部感染;隨訪三尖瓣無反流13 例,Ⅰ級反流14 例,Ⅱ級反流2 例,Ⅲ級反流1 例,無Ⅳ級反流。Kay 成形術(shù)組隨訪時間為(18.96±9.23)個月,遠(yuǎn)期死亡2 例,分別死于頑固性右心衰竭和腦出血;隨訪無三尖瓣反流9 例,Ⅰ級反流12 例,Ⅱ級反流5 例,Ⅲ級反流2 例,Ⅳ級反流2 例。術(shù)后早期改良組和Kay 成形術(shù)組右心房橫徑[(4.51±0.85)cm vs. (5.69±1.21) cm]、右心室舒張期末內(nèi)徑[(2.85±0.45) cm vs.( 3.47±0.83) cm] 和三尖瓣反流面積[(4.17±2.54) cm2 vs.( 25.12±2.39 cm2)] 較術(shù)前均明顯下降(P < 0.05);術(shù)后隨訪改良組和Kay成形術(shù)組右心房橫徑[(3.95±0.66) cm vs.( 4.52±0.38) cm,P=0.705] 差異無統(tǒng)計學(xué)意義,右心室舒張期末內(nèi)徑[(2.59±0.63)cm vs.( 2.98±0.47) cm, P=0.002] 和三尖瓣反流面積[(8.76±3.45) cm2 vs.( 12.16±5.28) cm2, P=0.004] 改良組優(yōu)于Kay 成形術(shù)組。 結(jié)論 改良三尖瓣成形術(shù)的遠(yuǎn)期成形效果優(yōu)于Kay 成形術(shù)。

引用本文: 王俊,陳亮,陳廣明等. 改良三尖瓣成形術(shù)的效果評價. 中國胸心血管外科臨床雜志, 2012, 19(1): 80-82. doi: 復(fù)制

1.  Frater R. Tricuspid insufficiency. J Thorac Cardiovasc Surg, 2001, 122(3):427-429.
2.  Shiran A, Sagie A. Tricuspid regurgitation in mitral valve disease: incidence, prognostic implications, mechanism, and management. J Am Coll Cardiol, 2009, 53(5):401-408.
3.  De Vega NG, De Rábago G, Castillón L, et al. A new tricuspid repair. Short-term clinical results in 23 cases. J Cardiovasc Surg (Torino), 1973, Spec No: 384-386.
4.  Kay GL, Morita S, Mendez M, et al. Tricuspid regurgitation associated with mitral valve disease: repair and replacement. Ann Thorac Surg, 1989, 48 (Suppl 3): S93-S95.
5.  Raja SG. Dreyfus GD. Surgery for functional tricuspid regurgitation: current techniques, outcomes and emerging concepts. Expert Rev Cardiovasc Ther, 2009, 7(1): 73-84.
6.  Lawrence SC, Gerald M, Ann FB, et al. Intraoperative evaluation of mitral regurgitation by doppler color flow mapping. Circulation, 1987, 76(3 Pt 2):Ⅲ108-116.
7.  Lambertz H, Flachskampf FA, Minale C. Tricuspid regurgitation in patients with mitral valve disease: who need tricuspid repair? Circulation, 1998, 78(2):210-211.
8.  Antunes MJ, Barlow JB. Management of tricuspid valve regurgitation. Heart, 2007, 93(2):271-276.
9.  Sugimoto T, Okada M, Ozaki N, et al. Long-term evaluation of treatment for functional tricuspid regurgitation with regurgitant volume: characteristic difference based on primary cardiac lesion. J Thorac Cardiovasc Surg, 1999, 117(3):463-471.
10.  Tei C, Pilgrim JP, Shah PM,et al. The tricuspid valve annulus: study of size and motion in normal subjects and in patients with tricuspid regurgitation. Circulation, 1982, 66(3):665-671.
11.  Silver MD, Lam JH, Ranganathan N, et al. Morphology of the human tricuspid valve. Circulation, 1971, 43(3):333-348.
12.  McCarthy PM, Bhudia SK, Rajeswaran J, et al. Tricuspid valve repair durability and risk factors for failure. J Thorac Cardiovasc Surg, 2004, 127(3):674-685.
13.  Dreyfus GD, Corbi PJ, Chan KM, et al. Secondary tricuspid regurgitation or dilation: Which should be the criteria for surgical repair? Ann Thorac Surg, 2005, 79(1):127-132.
14.  Xiao XJ, Huang HL, Zhang JF, et al. Surgical treatment of late tricuspid regurgitation after left cardiac valve replacement. Heart Lung Circ, 2004, 13(1):65-69.
15.  Porter A, Shapia Y, Wurzel M, et al. Tricuspid regurgitation late after mitral valve replacement clinical an echocardiography evaluation. J Heart Valve Dis, 1999, 8(1):57-62.
  1. 1.  Frater R. Tricuspid insufficiency. J Thorac Cardiovasc Surg, 2001, 122(3):427-429.
  2. 2.  Shiran A, Sagie A. Tricuspid regurgitation in mitral valve disease: incidence, prognostic implications, mechanism, and management. J Am Coll Cardiol, 2009, 53(5):401-408.
  3. 3.  De Vega NG, De Rábago G, Castillón L, et al. A new tricuspid repair. Short-term clinical results in 23 cases. J Cardiovasc Surg (Torino), 1973, Spec No: 384-386.
  4. 4.  Kay GL, Morita S, Mendez M, et al. Tricuspid regurgitation associated with mitral valve disease: repair and replacement. Ann Thorac Surg, 1989, 48 (Suppl 3): S93-S95.
  5. 5.  Raja SG. Dreyfus GD. Surgery for functional tricuspid regurgitation: current techniques, outcomes and emerging concepts. Expert Rev Cardiovasc Ther, 2009, 7(1): 73-84.
  6. 6.  Lawrence SC, Gerald M, Ann FB, et al. Intraoperative evaluation of mitral regurgitation by doppler color flow mapping. Circulation, 1987, 76(3 Pt 2):Ⅲ108-116.
  7. 7.  Lambertz H, Flachskampf FA, Minale C. Tricuspid regurgitation in patients with mitral valve disease: who need tricuspid repair? Circulation, 1998, 78(2):210-211.
  8. 8.  Antunes MJ, Barlow JB. Management of tricuspid valve regurgitation. Heart, 2007, 93(2):271-276.
  9. 9.  Sugimoto T, Okada M, Ozaki N, et al. Long-term evaluation of treatment for functional tricuspid regurgitation with regurgitant volume: characteristic difference based on primary cardiac lesion. J Thorac Cardiovasc Surg, 1999, 117(3):463-471.
  10. 10.  Tei C, Pilgrim JP, Shah PM,et al. The tricuspid valve annulus: study of size and motion in normal subjects and in patients with tricuspid regurgitation. Circulation, 1982, 66(3):665-671.
  11. 11.  Silver MD, Lam JH, Ranganathan N, et al. Morphology of the human tricuspid valve. Circulation, 1971, 43(3):333-348.
  12. 12.  McCarthy PM, Bhudia SK, Rajeswaran J, et al. Tricuspid valve repair durability and risk factors for failure. J Thorac Cardiovasc Surg, 2004, 127(3):674-685.
  13. 13.  Dreyfus GD, Corbi PJ, Chan KM, et al. Secondary tricuspid regurgitation or dilation: Which should be the criteria for surgical repair? Ann Thorac Surg, 2005, 79(1):127-132.
  14. 14.  Xiao XJ, Huang HL, Zhang JF, et al. Surgical treatment of late tricuspid regurgitation after left cardiac valve replacement. Heart Lung Circ, 2004, 13(1):65-69.
  15. 15.  Porter A, Shapia Y, Wurzel M, et al. Tricuspid regurgitation late after mitral valve replacement clinical an echocardiography evaluation. J Heart Valve Dis, 1999, 8(1):57-62.